Skip to main content

Two Common Antiseizure Medications Do Not Harm Child Neurodevelopment

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 3, 2024.

via HealthDay

TUESDAY, Dec. 3, 2024 -- Fetal exposure to two common antiseizure medications (ASMs) does not seem to negatively impact children's neurological development at age 6 years, according to a study published online Nov. 25 in JAMA Neurology.

Kimford J. Meador, M.D., from the Stanford University School of Medicine in Palo Alto, California, and colleagues compared the outcomes of 6-year-old children of women with epilepsy (WWE) versus those of healthy women to assess the association of outcomes to third-trimester ASM exposures. The analysis included 298 children of WWE and 89 children of healthy women.

The researchers found that the two groups of children did not differ on the Verbal Index Score, but there was variance based on the amount of ASM exposure. Lamotrigine showed positive exposure-dependent associations, while levetiracetam showed negative exposure-dependent associations. Across ASMs, exposure-dependent outcomes differed. Three-quarters of WWE (78 percent) were taking lamotrigine or levetiracetam alone or in combination, so assessment of other ASMs was limited. There were positive associations for folate supplementation during the first 12 weeks of pregnancy with cognition and behavior, with no signal for risks at higher folate doses.

"Because all ASMs are potential teratogens, and teratogens act in an exposure-dependent manner, the clinical challenge is to provide a dose sufficiently high to protect the mother and fetus from seizures but at the lowest effective concentration to minimize fetal risks," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Brain Abnormalities Seen in Epilepsy Patients With Psych Comorbidities

TUESDAY, Sept. 23, 2025 -- Epilepsy patients with versus without psychiatric comorbidities have a higher proportion of abnormal brain magnetic resonance imaging and...

Periodic Limb Movements Occur Frequently in Persons With Epilepsy

MONDAY, Sept. 22, 2025 -- Periodic limb movements (PLMs) occur frequently among persons with epilepsy (PWE) but do not occur more often than among those with obstructive sleep...

Slightly More Than Half of Pregnant Women With Epilepsy See Neurologist in Year Predelivery

FRIDAY, Sept. 19, 2025 -- Just over half (55 percent) of pregnant women with epilepsy (WWE) saw a neurologist in the year prior to delivery, according to a study presented at the...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.